182 related articles for article (PubMed ID: 18001)
21. The Sydney multicentre study of Parkinson's disease. The first 18 months.
Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
[TBL] [Abstract][Full Text] [Related]
22. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease.
Savery F
Dis Nerv Syst; 1977 Aug; 38(8):605-8. PubMed ID: 328244
[TBL] [Abstract][Full Text] [Related]
23. Sinemet CR for Parkinson's disease.
Med Lett Drugs Ther; 1991 Oct; 33(854):92-3. PubMed ID: 1895993
[No Abstract] [Full Text] [Related]
24. The treatment of parkinsonism.
Godwin-Austen R
Practitioner; 1975 Oct; 215(1288):445-51. PubMed ID: 1202468
[No Abstract] [Full Text] [Related]
25. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
Shoulson I
Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
[No Abstract] [Full Text] [Related]
26. [Parkinsonism].
Kaumeier S
Fortschr Med; 1978 Jul; 96(28):1397-404. PubMed ID: 27434
[No Abstract] [Full Text] [Related]
27. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
Londoõ R
Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
[TBL] [Abstract][Full Text] [Related]
28. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias.
Mark MH; Sage JI
Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565
[TBL] [Abstract][Full Text] [Related]
29. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
30. Update on antiparkinsonian agents.
Weiner M
Geriatrics; 1982 Sep; 37(9):81-4, 89-91. PubMed ID: 6125455
[No Abstract] [Full Text] [Related]
31. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
Lombardo L; De la Garza R
Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
[TBL] [Abstract][Full Text] [Related]
32. Medical treatment of Parkinson's disease.
Ahlskog JE
Compr Ther; 1989 Mar; 15(3):53-9. PubMed ID: 2650977
[No Abstract] [Full Text] [Related]
33. [Parkinson disease. The clinical picture and therapy].
Huber M
Dtsch Med Wochenschr; 1988 Jun; 113(24):992-8. PubMed ID: 2897901
[No Abstract] [Full Text] [Related]
34. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Pahwa R; Koller WC
Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
[No Abstract] [Full Text] [Related]
35. Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa.
Lipper S
Lancet; 1976 Sep; 2(7985):571-2. PubMed ID: 60643
[No Abstract] [Full Text] [Related]
36. Controlled-release carbidopa-levodopa: old drug--new drug. Introduction.
Koller WC
Neurology; 1992 Jan; 42(1 Suppl 1):4-5; discussion 57-60. PubMed ID: 1549200
[No Abstract] [Full Text] [Related]
37. [A year of treatment with carbidopa and levodopa in Parkinsonian patients].
Martínez-Lage JM; Marti-Massó JF; Delgado G; Carreray N; Del Amo F
Rev Clin Esp; 1974 Sep; 134(6):535-42. PubMed ID: 4450036
[No Abstract] [Full Text] [Related]
38. Comprehensive care of the patient with Parkinson's disease.
Lannon MC; Thomas CA; Bratton M; Jost MG; Lockhart-Pretti P
J Neurosci Nurs; 1986 Jun; 18(3):121-31. PubMed ID: 2941497
[TBL] [Abstract][Full Text] [Related]
39. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
[TBL] [Abstract][Full Text] [Related]
40. What to do when Sinemet fails: Part one.
Klawans HL
Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
